Record-breaking study: Scientists analyzed blood protein genetics from over 78,000 participants across 38 cohorts, marking the largest study of its kind. Drug repurposing potential: Findings suggest ...

Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of ...

Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...

Penn researchers are developing a blood test to predict kidney disease risk in Black Americans, who face disproportionately ...

The era of genetic medicines has ushered in novel and exciting ways of treating genetic diseases, one of which includes bringing to reality the promise of a one-time treatment by addressing the root ...

Researchers have found that being a carrier for sickle cell disease, known as having sickle cell trait, increases the risk of blood clots, a risk that is the same among diverse human populations that ...

Add Yahoo as a preferred source to see more of our stories on Google. In a major leap for genetic diagnostics, scientists from the University of Melbourne and the Murdoch Children's Research Institute ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

For the first time in Germany, a long-term, sustainable access agreement to a gene therapy has been established for people living with sickle cell disease and transfusion-dependent beta thalassemia,” ...

Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders ...